100% Genuine
Sealed pack
Pharmacist-verified
Quality assured
Pan-India delivery
Standard shipping
100% Genuine
Sealed pack
Pharmacist-verified
Quality assured
Pan-India delivery
Standard shipping
Important advisories specific to this medicine.
Pregnancy
Consult doctor (not recommended unless clearly needed; insulin preferred in pregnancy)
Breastfeeding
Vildapride M 50/500 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Alcohol
Type 2 diabetes mellitus in adults to improve blood glucose control when diet and exercise alone are not enough; used when dual therapy with metformin and a DPP-4 inhibitor is appropriate.
Nausea, vomiting, diarrhea, abdominal pain, loss of appetite, metallic taste, headache, dizziness, upper respiratory tract infection, hypoglycemia (more likely with other antidiabetics), flatulence
Vildagliptin is a DPP-4 inhibitor that increases incretin hormones (GLP-1, GIP), leading to glucose-dependent increase in insulin release and reduced glucagon. Metformin decreases hepatic glucose production and improves insulin sensitivity, lowering fasting and post-meal glucose.

Brand
MICRO LABS
View all products from this brand
Every order from PingMeDoc Pharmacy is reviewed by a licensed pharmacist before dispatch. Prescription medicines ship only after the Rx is verified.
Manufacturer: Micro Labs Ltd
Medical disclaimer
Product information is for awareness only and does not replace medical advice. For Rx medicines, a valid prescription is required. Consult your doctor or pharmacist for personalised guidance.
Sources: CDSCO/Indian labeling norms, manufacturer labeling, established medical literature (metformin and vildagliptin SmPC/monographs), standard diabetes treatment guidelines
Avoid
Kidney
Vildapride M 50/500 Tablet should be used with caution in patients with kidney disease. Dose adjustment of Vildapride M 50/500 Tablet may be needed. Please consult your doctor.
Liver
Vildapride M 50/500 Tablet is probably unsafe to use in patients with liver disease and should be avoided. Please consult your doctor.
Drug | Tablet
Type 2 diabetes mellitus in adults to improve blood glucose control when diet and exercise alone are not enough; used when dual therapy with metformin and a DPP-4 inhibitor is appropriate.
Vildagliptin is a DPP-4 inhibitor that increases incretin hormones (GLP-1, GIP), leading to glucose-dependent increase in insulin release and reduced glucagon. Metformin decreases hepatic glucose production and improves insulin sensitivity, lowering fasting and post-meal glucose.
Tablet for oral use. Take as prescribed, usually with meals to reduce stomach upset. Swallow whole with water; do not crush/chew. Take at the same time daily and continue diet/exercise plan.
Nausea, vomiting, diarrhea, abdominal pain, loss of appetite, metallic taste, headache, dizziness, upper respiratory tract infection, hypoglycemia (more likely with other antidiabetics), flatulence
Prescription only (Schedule H). Risk of lactic acidosis with metformin (higher in kidney impairment, dehydration, sepsis, hypoxia, heavy alcohol use); stop and seek urgent care if rapid breathing, severe weakness, abdominal pain, or unusual sleepiness occur. Avoid/use with caution in renal impairment; check eGFR before start and periodically. Use caution in hepatic impairment. Risk of pancreatitis with vildagliptin—stop if severe persistent abdominal pain. Monitor for hypersensitivity reactions and rare bullous pemphigoid. Temporarily stop metformin before iodinated contrast/surgery as advised. Monitor vitamin B12 with long-term use.
Alcohol (increases lactic acidosis risk), iodinated contrast media, carbonic anhydrase inhibitors (e.g., topiramate, acetazolamide), cationic drugs affecting renal tubular secretion (e.g., cimetidine), diuretics and ACE inhibitors/ARBs (may affect renal function), corticosteroids and thiazides (may raise glucose), insulin/sulfonylureas (increased hypoglycemia risk)
Store below 25°C in a dry place, protected from moisture and light. Keep in original blister pack and out of reach of children.
Galvus Met 50/500 Tablet, Jalra M 50/500 Tablet, Zomelis Met 50/500 Tablet, Vysov-M 50/500 Tablet, Vildamet 50/500 Tablet
Tablet for oral use. Take as prescribed, usually with meals to reduce stomach upset. Swallow whole with water; do not crush/chew. Take at the same time daily and continue diet/exercise plan.
Store below 25°C in a dry place, protected from moisture and light. Keep in original blister pack and out of reach of children.
Yes, this product requires a valid prescription (Rx). Upload it during checkout when prompted.
Yes. Prices and availability can change based on inventory and serviceability. The latest details are shown at checkout.
Select a variant, add to cart, enter delivery address, upload prescription if required, and pay securely.
Other products patients also browse for similar needs.
Same brand, other products you might also want.